Short-term: Key measurements of effect (measured at T1 and T2 in Groups A and B) | |
Self efficacy | The Self-Efficacy for Managing Chronic Disease (SEM-CD) scale (6 items) developed by the Stanford Patient Education Research Center [67]. |
Empowerment | Proxy of “The Health Education Impact questionnaire (heiQ)” [77] |
Comorbidity | The Disease Burden Morbidity assessment (DBMA) [64] |
Mid-term: Key measurements of effect (measured at T1 and T3 in Groups A and C) | |
Health behaviour | Behaviour Risk Factor Survey System Questionnaire (eating habits, physical activity, smoking and alcohol consumption) [65] |
Functional health status/quality of life | |
Psychological well-being | K-6 [62] |
Comorbidity | The Disease Burden Morbidity Assessment (DBMA) [64] |
Other variables | |
Participant characteristics | Sex, age, socioeconomic status, education, referral diagnosis |
Co-intervention | Questionnaire on co-interventions |